Literature DB >> 467851

Insulin and glucagon concentrations in portal and peripheral veins in patients with hepatic cirrhosis.

A V Greco, F Crucitti, G Ghirlanda, R Manna, L Altomonte, A G Rebuzzi, A Bertoli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 467851     DOI： 10.1007/bf01222973

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  39 in total

1.  Oscillation in insulin response to glucose stimulation. Measurements in the portal vein in man in the postoperative period.

Authors:  R Bittner; H G Beger; E Kraas
Journal:  Horm Metab Res       Date:  1974-09       Impact factor: 2.936

2.  Behavior of pancreatic glucagon, insulin, and HGH in liver cirrhosis, after arginine and I.V. glucose.

Authors:  A V Greco; G Ghirlanda; C Patrono; G Fedili; R Manna
Journal:  Acta Diabetol Lat       Date:  1974 Jul-Aug

3.  Quantitative study on the potentiating effect of arginine on glucose-induced insulin response in healthy, prediabetic, and diabetic subjects.

Authors:  S Efendić; E Cerasi; R Luft
Journal:  Diabetes       Date:  1974-03       Impact factor: 9.461

4.  The behaviour of insulinaemia in patients ith liver cirrhosis after intravenous administration of glucose, tolbutamide and glucagon.

Authors:  T Kasperska; J Lawecki; H Rogala; A Czyzyk
Journal:  Diabetologia       Date:  1971-10       Impact factor: 10.122

5.  Coated charcoal immunoassay of insulin.

Authors:  V Herbert; K S Lau; C W Gottlieb; S J Bleicher
Journal:  J Clin Endocrinol Metab       Date:  1965-10       Impact factor: 5.958

6.  Decreased insulin production, elevated growth hormone levels, and glucose intolerance in liver disease.

Authors:  A Hernandez; E Zorrilla; H Gershberg
Journal:  J Lab Clin Med       Date:  1969-01

7.  Influence of uremia and hemodialysis on the turnover and metabolic effects of glucagon.

Authors:  R S Sherwin; C Bastl; F O Finkelstein; M Fisher; H Black; R Hendler; P Felig
Journal:  J Clin Invest       Date:  1976-03       Impact factor: 14.808

8.  Removal of insulin by perfused rat liver: effect of concentration.

Authors:  C E Mondon; J M Olefsky; C B Dolkas; G M Reaven
Journal:  Metabolism       Date:  1975-02       Impact factor: 8.694

9.  Hyperglucagonemia in cirrhosis: altered secretion and sensitivity to glucagon.

Authors:  R S Sherwin; M Fisher; J Bessoff; N Snyder; R Hendler; H O Conn; P Felig
Journal:  Gastroenterology       Date:  1978-06       Impact factor: 22.682

10.  Hyperinsulinism of hepatic cirrhosis: Diminished degradation or hypersecretion?

Authors:  D G Johnson; K G Alberti; O K Faber; C Binder
Journal:  Lancet       Date:  1977-01-01       Impact factor: 79.321
View more
  25 in total

1.  The effects of intraoperative glucose infusion on portal blood insulin concentration and hepatic mitochondrial redox state during surgery: comparison of short-term and continuous infusions.

Authors:  J Hayakawa; H Motohashi; M Sairenji; O Kobayashi; M Takahashi; Y Usuda
Journal:  Surg Today       Date:  2000       Impact factor: 2.549

2.  Acute effects of distal pancreatectomy on portal and peripheral blood insulin concentrations in patients undergoing total gastrectomy.

Authors:  J Hayakawa; A Tsuburaya; H Motohashi; M Sairenji; O Kobayashi; K Suzuki; Y Usuda
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

3.  Glucose intolerance and pancreatic endocrine dysfunction in dogs with obstructive jaundice.

Authors:  H Obata; A Koga
Journal:  Gastroenterol Jpn       Date:  1988-12

4.  Feedback inhibition of insulin and glucagon secretion by insulin is altered in abdominal obesity with normal or impaired glucose tolerance.

Authors:  P Cavallo-Perin; A Bruno; L Scaglione; G Gruden; M Cassader; G Pagano
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

5.  Characteristic features of plasma amino acid, plasma pancreatic glucagon, serum insulin concentrations in cirrhotic patients with histories of chronic alcohol consumption.

Authors:  H Nakatsukasa; A Watanabe; M Kobayashi; T Shiota; M Fujiwara; N Takei; Y Yamauchi; S Hayashi; H Nagashima
Journal:  Gastroenterol Jpn       Date:  1984-04

6.  The presence of glucagon in ascitic fluid in cirrhotic patients.

Authors:  U M Kabadi; M S Uddinn; A B Eisenstein
Journal:  J Endocrinol Invest       Date:  1983-06       Impact factor: 4.256

7.  Enhanced hepatic insulin sensitivity, but peripheral insulin resistance in patients with type 1 (insulin-dependent) diabetes.

Authors:  O Hother-Nielsen; O Schmitz; J Bak; H Beck-Nielsen
Journal:  Diabetologia       Date:  1987-11       Impact factor: 10.122

8.  Insulin, C-peptide and glucagon levels during OGTT in hepatic cirrhosis and in patients with prehepatic block.

Authors:  L Gerö; L Korányi; F Szalay; B Büki; G Tamás
Journal:  Acta Diabetol Lat       Date:  1982 Jan-Mar

9.  Insulin and glucagon concentrations in the portal and peripheral blood in liver-injured and partially hepatectomized rats.

Authors:  A Watanabe; T Higashi; S Hayashi; H Nagashima
Journal:  Gastroenterol Jpn       Date:  1982

10.  Serum levels of true insulin, C-peptide and proinsulin in peripheral blood of patients with cirrhosis.

Authors:  T Kasperska-Czyźykowa; L G Heding; A Czyzyk
Journal:  Diabetologia       Date:  1983-12       Impact factor: 10.122
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.